These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. J Biol Chem; 2004 Jan 09; 279(2):1323-9. PubMed ID: 14581482 [Abstract] [Full Text] [Related]
5. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha. Katsuyama K, Hirata Y. J Biochem; 2001 Apr 09; 129(4):585-91. PubMed ID: 11275558 [Abstract] [Full Text] [Related]
6. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Doi M, Shichiri M, Katsuyama K, Ishimaru S, Hirata Y. Atherosclerosis; 2002 Jan 09; 160(1):123-32. PubMed ID: 11755929 [Abstract] [Full Text] [Related]
9. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor: involvement of the MEK/ERK pathway. Nakata S, Tsutsui M, Shimokawa H, Tamura M, Tasaki H, Morishita T, Suda O, Ueno S, Toyohira Y, Nakashima Y, Yanagihara N. Arterioscler Thromb Vasc Biol; 2005 Dec 09; 25(12):2502-8. PubMed ID: 16224055 [Abstract] [Full Text] [Related]
17. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta. Hecker M, Preiss C, Schini-Kerth VB. Br J Pharmacol; 1997 Mar 09; 120(6):1067-74. PubMed ID: 9134219 [Abstract] [Full Text] [Related]
19. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. Katsuyama K, Shichiri M, Marumo F, Hirata Y. Arterioscler Thromb Vasc Biol; 1998 Nov 09; 18(11):1796-802. PubMed ID: 9812920 [Abstract] [Full Text] [Related]